nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0487	0.0655	CbGbCtD
Palonosetron—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0457	0.0616	CbGbCtD
Palonosetron—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0457	0.0616	CbGbCtD
Palonosetron—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0414	0.0557	CbGbCtD
Palonosetron—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0401	0.0539	CbGbCtD
Palonosetron—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0377	0.0507	CbGbCtD
Palonosetron—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0377	0.0507	CbGbCtD
Palonosetron—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0347	0.0467	CbGbCtD
Palonosetron—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0341	0.0459	CbGbCtD
Palonosetron—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0341	0.0459	CbGbCtD
Palonosetron—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0314	0.0422	CbGbCtD
Palonosetron—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0294	0.0396	CbGbCtD
Palonosetron—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0286	0.0384	CbGbCtD
Palonosetron—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0258	0.0348	CbGbCtD
Palonosetron—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0258	0.0348	CbGbCtD
Palonosetron—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0255	0.0343	CbGbCtD
Palonosetron—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.024	0.0323	CbGbCtD
Palonosetron—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.024	0.0323	CbGbCtD
Palonosetron—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0217	0.0292	CbGbCtD
Palonosetron—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0217	0.0292	CbGbCtD
Palonosetron—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0187	0.0252	CbGbCtD
Palonosetron—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0182	0.0244	CbGbCtD
Palonosetron—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0164	0.0221	CbGbCtD
Palonosetron—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0164	0.0221	CbGbCtD
Palonosetron—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0157	0.0212	CbGbCtD
Palonosetron—HTR3A—nerve—acquired immunodeficiency syndrome	0.00247	0.217	CbGeAlD
Palonosetron—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000965	0.0848	CbGeAlD
Palonosetron—HTR3A—digestive system—acquired immunodeficiency syndrome	0.000719	0.0632	CbGeAlD
Palonosetron—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000698	0.0614	CbGeAlD
Palonosetron—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000687	0.0604	CbGeAlD
Palonosetron—HTR3A—blood—acquired immunodeficiency syndrome	0.000685	0.0602	CbGeAlD
Palonosetron—HTR3A—lung—acquired immunodeficiency syndrome	0.0006	0.0527	CbGeAlD
Palonosetron—HTR3A—nervous system—acquired immunodeficiency syndrome	0.000556	0.0488	CbGeAlD
Palonosetron—HTR3A—central nervous system—acquired immunodeficiency syndrome	0.000535	0.047	CbGeAlD
Palonosetron—HTR3A—brain—acquired immunodeficiency syndrome	0.000425	0.0373	CbGeAlD
Palonosetron—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000371	0.0326	CbGeAlD
Palonosetron—CYP1A2—blood—acquired immunodeficiency syndrome	0.000353	0.0311	CbGeAlD
Palonosetron—CYP1A2—lung—acquired immunodeficiency syndrome	0.00031	0.0272	CbGeAlD
Palonosetron—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000269	0.0236	CbGeAlD
Palonosetron—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000264	0.0232	CbGeAlD
Palonosetron—CYP3A4—blood—acquired immunodeficiency syndrome	0.000256	0.0225	CbGeAlD
Palonosetron—CYP2D6—blood—acquired immunodeficiency syndrome	0.000252	0.0221	CbGeAlD
Palonosetron—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000227	0.000924	CcSEcCtD
Palonosetron—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000226	0.00092	CcSEcCtD
Palonosetron—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000225	0.000917	CcSEcCtD
Palonosetron—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.000917	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000225	0.000917	CcSEcCtD
Palonosetron—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000224	0.000912	CcSEcCtD
Palonosetron—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000224	0.000912	CcSEcCtD
Palonosetron—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000224	0.00091	CcSEcCtD
Palonosetron—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000223	0.000906	CcSEcCtD
Palonosetron—Rash—Didanosine—acquired immunodeficiency syndrome	0.000222	0.000904	CcSEcCtD
Palonosetron—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.000904	CcSEcCtD
Palonosetron—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000222	0.000904	CcSEcCtD
Palonosetron—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000222	0.000904	CcSEcCtD
Palonosetron—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000222	0.000903	CcSEcCtD
Palonosetron—Headache—Didanosine—acquired immunodeficiency syndrome	0.000221	0.000898	CcSEcCtD
Palonosetron—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00022	0.000897	CcSEcCtD
Palonosetron—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00022	0.000896	CcSEcCtD
Palonosetron—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00022	0.000895	CcSEcCtD
Palonosetron—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00022	0.000895	CcSEcCtD
Palonosetron—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000219	0.000893	CcSEcCtD
Palonosetron—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000219	0.000893	CcSEcCtD
Palonosetron—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000219	0.00089	CcSEcCtD
Palonosetron—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000218	0.000888	CcSEcCtD
Palonosetron—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000218	0.000886	CcSEcCtD
Palonosetron—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000217	0.000885	CcSEcCtD
Palonosetron—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000217	0.000884	CcSEcCtD
Palonosetron—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000217	0.000884	CcSEcCtD
Palonosetron—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000217	0.000882	CcSEcCtD
Palonosetron—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000216	0.000881	CcSEcCtD
Palonosetron—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000216	0.00088	CcSEcCtD
Palonosetron—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000216	0.000878	CcSEcCtD
Palonosetron—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000216	0.000878	CcSEcCtD
Palonosetron—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000215	0.000875	CcSEcCtD
Palonosetron—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000215	0.000875	CcSEcCtD
Palonosetron—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000215	0.000875	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.000872	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000213	0.000869	CcSEcCtD
Palonosetron—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000213	0.000868	CcSEcCtD
Palonosetron—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000213	0.000868	CcSEcCtD
Palonosetron—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000213	0.000867	CcSEcCtD
Palonosetron—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000213	0.000867	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000213	0.000866	CcSEcCtD
Palonosetron—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000211	0.000861	CcSEcCtD
Palonosetron—Pain—Indinavir—acquired immunodeficiency syndrome	0.000211	0.000861	CcSEcCtD
Palonosetron—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000211	0.00086	CcSEcCtD
Palonosetron—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000211	0.00086	CcSEcCtD
Palonosetron—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.000858	CcSEcCtD
Palonosetron—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.000857	CcSEcCtD
Palonosetron—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00021	0.000856	CcSEcCtD
Palonosetron—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00021	0.000856	CcSEcCtD
Palonosetron—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00021	0.000855	CcSEcCtD
Palonosetron—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00021	0.000854	CcSEcCtD
Palonosetron—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000209	0.000852	CcSEcCtD
Palonosetron—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000209	0.000852	CcSEcCtD
Palonosetron—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000209	0.00085	CcSEcCtD
Palonosetron—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.000848	CcSEcCtD
Palonosetron—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000208	0.0182	CbGeAlD
Palonosetron—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.000845	CcSEcCtD
Palonosetron—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.000845	CcSEcCtD
Palonosetron—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.000845	CcSEcCtD
Palonosetron—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.000842	CcSEcCtD
Palonosetron—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000206	0.000839	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.000839	CcSEcCtD
Palonosetron—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000206	0.000837	CcSEcCtD
Palonosetron—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.000835	CcSEcCtD
Palonosetron—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000204	0.018	CbGeAlD
Palonosetron—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000204	0.000829	CcSEcCtD
Palonosetron—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.000828	CcSEcCtD
Palonosetron—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000203	0.000827	CcSEcCtD
Palonosetron—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.000826	CcSEcCtD
Palonosetron—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000203	0.000826	CcSEcCtD
Palonosetron—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.000825	CcSEcCtD
Palonosetron—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000202	0.000823	CcSEcCtD
Palonosetron—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000202	0.000823	CcSEcCtD
Palonosetron—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000202	0.000823	CcSEcCtD
Palonosetron—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000202	0.000821	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.000821	CcSEcCtD
Palonosetron—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000201	0.00082	CcSEcCtD
Palonosetron—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000201	0.00082	CcSEcCtD
Palonosetron—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000201	0.00082	CcSEcCtD
Palonosetron—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.000817	CcSEcCtD
Palonosetron—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000201	0.000817	CcSEcCtD
Palonosetron—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.0002	0.0176	CbGeAlD
Palonosetron—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.0002	0.000813	CcSEcCtD
Palonosetron—Pain—Efavirenz—acquired immunodeficiency syndrome	0.0002	0.000813	CcSEcCtD
Palonosetron—Rash—Nevirapine—acquired immunodeficiency syndrome	0.0002	0.000813	CcSEcCtD
Palonosetron—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000199	0.000812	CcSEcCtD
Palonosetron—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.000811	CcSEcCtD
Palonosetron—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000199	0.000811	CcSEcCtD
Palonosetron—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.000809	CcSEcCtD
Palonosetron—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000198	0.000808	CcSEcCtD
Palonosetron—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.000806	CcSEcCtD
Palonosetron—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.000806	CcSEcCtD
Palonosetron—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.000805	CcSEcCtD
Palonosetron—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.000803	CcSEcCtD
Palonosetron—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.000802	CcSEcCtD
Palonosetron—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000197	0.0173	CbGeAlD
Palonosetron—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.000801	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.0008	CcSEcCtD
Palonosetron—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000797	CcSEcCtD
Palonosetron—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.000796	CcSEcCtD
Palonosetron—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000195	0.000796	CcSEcCtD
Palonosetron—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000195	0.000796	CcSEcCtD
Palonosetron—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000195	0.000794	CcSEcCtD
Palonosetron—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000195	0.000794	CcSEcCtD
Palonosetron—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000194	0.000792	CcSEcCtD
Palonosetron—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.000791	CcSEcCtD
Palonosetron—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.000788	CcSEcCtD
Palonosetron—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000193	0.000787	CcSEcCtD
Palonosetron—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000193	0.000787	CcSEcCtD
Palonosetron—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.000787	CcSEcCtD
Palonosetron—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000193	0.000786	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.000785	CcSEcCtD
Palonosetron—Rash—Stavudine—acquired immunodeficiency syndrome	0.000193	0.000785	CcSEcCtD
Palonosetron—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.000784	CcSEcCtD
Palonosetron—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000193	0.000784	CcSEcCtD
Palonosetron—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000192	0.000782	CcSEcCtD
Palonosetron—Headache—Stavudine—acquired immunodeficiency syndrome	0.000192	0.00078	CcSEcCtD
Palonosetron—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000192	0.00078	CcSEcCtD
Palonosetron—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000778	CcSEcCtD
Palonosetron—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000778	CcSEcCtD
Palonosetron—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000191	0.000778	CcSEcCtD
Palonosetron—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000191	0.000776	CcSEcCtD
Palonosetron—Rash—Abacavir—acquired immunodeficiency syndrome	0.00019	0.000773	CcSEcCtD
Palonosetron—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00019	0.000773	CcSEcCtD
Palonosetron—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.000773	CcSEcCtD
Palonosetron—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.00019	0.000772	CcSEcCtD
Palonosetron—Headache—Abacavir—acquired immunodeficiency syndrome	0.000189	0.000768	CcSEcCtD
Palonosetron—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.000767	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.000767	CcSEcCtD
Palonosetron—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000188	0.000766	CcSEcCtD
Palonosetron—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000188	0.000766	CcSEcCtD
Palonosetron—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.000761	CcSEcCtD
Palonosetron—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.00076	CcSEcCtD
Palonosetron—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000186	0.000758	CcSEcCtD
Palonosetron—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000186	0.000757	CcSEcCtD
Palonosetron—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.000755	CcSEcCtD
Palonosetron—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000185	0.000752	CcSEcCtD
Palonosetron—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000185	0.000752	CcSEcCtD
Palonosetron—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.00075	CcSEcCtD
Palonosetron—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.00075	CcSEcCtD
Palonosetron—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.000748	CcSEcCtD
Palonosetron—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000183	0.000744	CcSEcCtD
Palonosetron—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000182	0.000742	CcSEcCtD
Palonosetron—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000182	0.000742	CcSEcCtD
Palonosetron—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000741	CcSEcCtD
Palonosetron—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000182	0.00074	CcSEcCtD
Palonosetron—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000182	0.00074	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.000738	CcSEcCtD
Palonosetron—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.000736	CcSEcCtD
Palonosetron—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.000732	CcSEcCtD
Palonosetron—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.000731	CcSEcCtD
Palonosetron—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000179	0.000729	CcSEcCtD
Palonosetron—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.000727	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000726	CcSEcCtD
Palonosetron—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000725	CcSEcCtD
Palonosetron—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000177	0.000722	CcSEcCtD
Palonosetron—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000722	CcSEcCtD
Palonosetron—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000722	CcSEcCtD
Palonosetron—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.00072	CcSEcCtD
Palonosetron—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000719	CcSEcCtD
Palonosetron—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000719	CcSEcCtD
Palonosetron—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000177	0.000719	CcSEcCtD
Palonosetron—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000177	0.000719	CcSEcCtD
Palonosetron—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000176	0.000716	CcSEcCtD
Palonosetron—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000713	CcSEcCtD
Palonosetron—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000175	0.000712	CcSEcCtD
Palonosetron—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000173	0.000704	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000704	CcSEcCtD
Palonosetron—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000172	0.000701	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000699	CcSEcCtD
Palonosetron—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000699	CcSEcCtD
Palonosetron—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000698	CcSEcCtD
Palonosetron—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000694	CcSEcCtD
Palonosetron—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000693	CcSEcCtD
Palonosetron—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000693	CcSEcCtD
Palonosetron—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000689	CcSEcCtD
Palonosetron—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000169	0.000689	CcSEcCtD
Palonosetron—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000169	0.000688	CcSEcCtD
Palonosetron—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.000688	CcSEcCtD
Palonosetron—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000687	CcSEcCtD
Palonosetron—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000168	0.000682	CcSEcCtD
Palonosetron—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000168	0.000682	CcSEcCtD
Palonosetron—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000167	0.000682	CcSEcCtD
Palonosetron—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.00068	CcSEcCtD
Palonosetron—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000166	0.000678	CcSEcCtD
Palonosetron—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.000673	CcSEcCtD
Palonosetron—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.000672	CcSEcCtD
Palonosetron—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.00067	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000667	CcSEcCtD
Palonosetron—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000666	CcSEcCtD
Palonosetron—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000163	0.000666	CcSEcCtD
Palonosetron—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000665	CcSEcCtD
Palonosetron—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000665	CcSEcCtD
Palonosetron—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.000662	CcSEcCtD
Palonosetron—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000661	CcSEcCtD
Palonosetron—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000661	CcSEcCtD
Palonosetron—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.000653	CcSEcCtD
Palonosetron—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.000651	CcSEcCtD
Palonosetron—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.000644	CcSEcCtD
Palonosetron—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000158	0.000643	CcSEcCtD
Palonosetron—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.00064	CcSEcCtD
Palonosetron—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.00064	CcSEcCtD
Palonosetron—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000157	0.00064	CcSEcCtD
Palonosetron—CYP2D6—brain—acquired immunodeficiency syndrome	0.000156	0.0137	CbGeAlD
Palonosetron—Rash—Indinavir—acquired immunodeficiency syndrome	0.000156	0.000635	CcSEcCtD
Palonosetron—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000156	0.000634	CcSEcCtD
Palonosetron—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000632	CcSEcCtD
Palonosetron—Headache—Indinavir—acquired immunodeficiency syndrome	0.000155	0.000631	CcSEcCtD
Palonosetron—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000154	0.000629	CcSEcCtD
Palonosetron—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.000623	CcSEcCtD
Palonosetron—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.00062	CcSEcCtD
Palonosetron—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000611	CcSEcCtD
Palonosetron—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000611	CcSEcCtD
Palonosetron—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.000605	CcSEcCtD
Palonosetron—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000604	CcSEcCtD
Palonosetron—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000148	0.000602	CcSEcCtD
Palonosetron—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.0006	CcSEcCtD
Palonosetron—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.000599	CcSEcCtD
Palonosetron—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000147	0.000598	CcSEcCtD
Palonosetron—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000597	CcSEcCtD
Palonosetron—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000146	0.000596	CcSEcCtD
Palonosetron—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000595	CcSEcCtD
Palonosetron—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000581	CcSEcCtD
Palonosetron—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.000578	CcSEcCtD
Palonosetron—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000576	CcSEcCtD
Palonosetron—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.000574	CcSEcCtD
Palonosetron—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.000573	CcSEcCtD
Palonosetron—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.000573	CcSEcCtD
Palonosetron—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.00057	CcSEcCtD
Palonosetron—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000569	CcSEcCtD
Palonosetron—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000139	0.000565	CcSEcCtD
Palonosetron—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.000556	CcSEcCtD
Palonosetron—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000554	CcSEcCtD
Palonosetron—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000554	CcSEcCtD
Palonosetron—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000547	CcSEcCtD
Palonosetron—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.00054	CcSEcCtD
Palonosetron—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000536	CcSEcCtD
Palonosetron—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000535	CcSEcCtD
Palonosetron—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.00053	CcSEcCtD
Palonosetron—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.00053	CcSEcCtD
Palonosetron—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000529	CcSEcCtD
Palonosetron—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000527	CcSEcCtD
Palonosetron—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000515	CcSEcCtD
Palonosetron—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000511	CcSEcCtD
Palonosetron—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000511	CcSEcCtD
Palonosetron—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.00051	CcSEcCtD
Palonosetron—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000507	CcSEcCtD
Palonosetron—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.0005	CcSEcCtD
Palonosetron—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000491	CcSEcCtD
Palonosetron—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000487	CcSEcCtD
Palonosetron—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000487	CcSEcCtD
Palonosetron—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000484	CcSEcCtD
Palonosetron—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000481	CcSEcCtD
Palonosetron—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000459	CcSEcCtD
